Looking to diversify beyond CURE? The ETFs below have the lowest correlation with CURE — they tend to move on their own, which can help reduce risk when the rest of your portfolio drops. The stock ideas table highlights individual companies that behave independently from CURE.
Best Diversifiers for CURE
1014 ETFs have low correlation with CURE (below 0.3), 28 of which are negatively correlated. The least correlated is ProShares UltraShort Yen (YCS) (Leveraged Currency) with a 1Y correlation of -0.28, down from -0.09 over 5 years.
| Symbol | Name | Correlation 1Y | Correlation 3Y | Correlation 5Y | Risk / Return Rank | Category | Compare |
|---|---|---|---|---|---|---|---|
| ProShares UltraShort Yen | -0.28 | -0.11 | -0.09 | 61 | Leveraged Currency | CURE vs YCS | |
| First Trust Alternative Absolute Return Strategy E... | -0.18 | -0.07 | -0.05 | 70 | Commodities | CURE vs FAAR | |
| VanEck Commodity Strategy ETF | -0.17 | -0.09 | — | 55 | Commodities | CURE vs PIT | |
| iShares iBonds Oct 2026 Term TIPS ETF | -0.17 | -0.08 | -0.08 | 98 | Inflation-Protected Bonds | CURE vs IBIC | |
| F/m Ultrashort Treasury Inflation-Protected Securi... | -0.16 | — | — | 97 | Inflation-Protected Bonds | CURE vs RBIL |
To view more results, upgrade your current subscription plan.
Low-Correlation Stock Ideas
If you're looking for individual stocks that move independently from CURE, these are worth exploring. The table shows U.S. companies ($1B+ market cap) with low correlation to CURE and solid risk/return profiles. The least correlated is Murphy USA Inc. (MUSA) (Consumer Cyclical) with a 1Y correlation of 0.10, down from 0.27 over 5 years.
| Symbol | Name | Correlation 1Y | Correlation 3Y | Correlation 5Y | Risk / Return Rank | Sector |
|---|---|---|---|---|---|---|
| Murphy USA Inc. | 0.10 | 0.20 | 0.27 | 70 | Consumer Cyclical | |
| argenx SE | 0.25 | 0.31 | 0.34 | 85 | Healthcare |
Build a portfolio that complements CURE
Add CURE to the Diversification Analyzer to see how it overlaps with your other holdings and which assets balance it best.
Analyze a portfolio with CURE